Park National Corp OH Purchases 6,276 Shares of HCA Healthcare, Inc. $HCA

Key Points

• Park National Corp OH increased its HCA Healthcare stake by 54.2% in the third quarter, purchasing 6,276 shares for a total holding of 17,851 shares valued at approximately $7.6 million.
• Analysts remain broadly positive on HCA, with 15 Buy, eight Hold, and one Sell rating; the stock has a “Moderate Buy” consensus and an average price target of $463.70.
• HCA reported quarterly revenue of $20.23 billion and earnings of $7.59 per share, exceeding estimates, while revenue rose 8.7% year over year. The company also paid a quarterly dividend of $0.78 per share, yielding about 0.7% annually.

Park National Corp OH lifted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 54.2% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 17,851 shares of the company's stock after purchasing an additional 6,276 shares during the quarter. Park National Corp OH's holdings in HCA Healthcare were worth $7,618,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. MidFirst Bank purchased a new stake in shares of HCA Healthcare during the second quarter worth approximately $28,000. Clearstead Trust LLC purchased a new position in shares of HCA Healthcare in the 2nd quarter valued at about $29,000. Cedar Mountain Advisors LLC purchased a new stake in HCA Healthcare during the first quarter worth approximately $33,000. MCF Advisors LLC lifted its position in shares of HCA Healthcare by 213.0% during the 4th quarter. MCF Advisors LLC now owns 72 shares of the company's stock worth $34,000 after buying an additional 49 shares during the last quarter. Finally, Delos Wealth Advisors LLC acquired a new stake in shares of HCA Healthcare in the 2nd quarter valued at about $35,000. Hedge funds and other institutional investors own 62.73% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on HCA shares. Royal Bank Of Canada reiterated an "outperform" rating and set a $435.00 price target on shares of HCA Healthcare in a research note on Tuesday, September 8th. Sanford C. Bernstein reaffirmed a "market perform" rating on shares of HCA Healthcare in a report on Wednesday, July 15th. Cantor Fitzgerald reissued an "overweight" rating on shares of HCA Healthcare in a report on Friday. Weiss Ratings restated a "hold (c+)" rating on shares of HCA Healthcare in a research note on Friday, September 4th. Finally, Oppenheimer decreased their price objective on shares of HCA Healthcare from $520.00 to $485.00 and set an "outperform" rating on the stock in a report on Monday, July 27th. Fifteen investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $463.70.

HCA Healthcare Stock Performance

Shares of NYSE:HCA traded up $7.63 during midday trading on Monday, hitting $434.32. 365,073 shares of the company's stock traded hands, compared to its average volume of 1,346,918. The firm's fifty day moving average price is $417.13 and its two-hundred day moving average price is $421.56. HCA Healthcare, Inc. has a twelve month low of $353.99 and a twelve month high of $556.52. The company has a market cap of $94.03 billion, a PE ratio of 14.54, a P/E/G ratio of 1.44 and a beta of 1.10.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating the consensus estimate of $7.56 by $0.03. The business had revenue of $20.23 billion for the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The company's revenue was up 8.7% on a year-over-year basis. During the same period last year, the business posted $6.84 EPS. As a group, equities research analysts anticipate that HCA Healthcare, Inc. will post 29.42 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th were given a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend was Wednesday, September 16th. HCA Healthcare's payout ratio is presently 10.45%.

HCA Healthcare Profile

HCA Healthcare, Inc is a provider of healthcare services in the United States. Through its network of hospitals and other healthcare facilities, the company delivers services including emergency and urgent care, surgery, inpatient and outpatient treatment, women's and children's care, cardiology, oncology, orthopedics, and behavioral health services.

HCA Healthcare also operates physician practices, ambulatory surgery centers, freestanding emergency rooms, diagnostic facilities, and other outpatient care sites.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.